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Type  II  glycogenosis  is  a fatal  disease  of infants
(1)  characterized  by  increased  concentration  of
tissue  glycogen  and  deficient  activity of lysosomal
acid  a  glucosidase  (a  glucosidase)  (2,  3).  In
hepatic  electron  photomicrographs,  Baudhuin
et al. observed vacuoles filled  with glycogen  which
they  interpreted  as  abnormal  lysosomes,  i.e.,  as
the  morphological  correlate  of  the  biochemical
deficiency  (4).  They  injected  intramuscularly
an  extract  of  the  fungus  Aspergillus  niger  which
Pazur  and  Ando had  shown  to  contain  enzymes
with  a  amylase,  amyloglucosidase,  and  maltase
activity  (5).  The  treatment  did  not  produce
appreciable  changes  of  the  abnormal  lysosomes.
In our  patient  such  changes  were  observed  after
prolonged, intravenous  administrations of an iden-
tically prepared fungal extract.
PATIENT  AND  METHODS
An alcohol  precipitate of Aspergillus niger served  as the
starting material.  20 g  of the powder were  extracted
with  600  cc  of  distilled  water  filtered  through  a
Buchner  funnel,  lyophilized,  dissolved  in  60  cc  of
0.9%  NaCI,  sterilized  with  passages  through  Milli-
pore  filters,  and  kept  in  the  refrigerator  until  used.
The  extract  had  a  protein  concentration  of  25
mg/cc.  It  catalyzed  the  essentially  complete  con-
version  of  glycogen  to  glucose  at  the  rate  of  22
moles  of glucose  formed  per  milligram  of  protein
per  minute at pH 4  and 37
0C.
The  liver  was  biopsied with  the  Menghini  needle
(6).  The  concentration  of glycogen  and  the  activity
of a  glucosidase in  the biopsy  specimens  were  deter-
mined  according  to  standard  procedures  (2)  and
as  reported  previously  (7).  For  ultrastructural
examination  the  tissue  specimens  were  immersed
immediately  after  the  biopsy  in  cold  (0-5
0C),
buffered  3%  glutaraldehyde  (pH  7.3;  0.1  M phos-
phate  buffer),  cut  into  small  pieces,  kept  in  the
refrigerator  for  24  hr,  and  washed  overnight  in
cold  buffer.  Postfixation  was  in  cold  (0-5°C),  buf-
fered  1%  OsO4  (pH  7.3;  0.1  M phosphate  buffer)
for  90  min.  After  dehydration  in  graded  ethanol,
the  tissue  was embedded  in Epon  812.  Thin sections
were  cut  with  glass  knives  on  a  Reichert  OMU2
ultramicrotome,  were  stained  on  uncoated  grids
with  uranyl  acetate  (5  min)  followed  by  lead  citrate
(5  min),  and  were  examined  in  a  Zeiss  EM  9  elec-
tron  microscope.
The  patient was a  3 month old negro  girl with the
typical  features  of  Type  II  glycogenosis  (1).  After
the  liver  biopsy,  the  extract  of  Aspergillus  niger
was  infused  intravenously  in  a  daily,  single  dose  of
7 cc.  The  activity  of a glucosidase  in the serum  had
a  half-life  of  110  min with a  peak  level  immediately
after  the  infusion  of  20  moles/cc/min.  The  treat-
ment  was  carried  out  for  18  days.  24  hr after  the
last  infusion,  a  glucosidase  activity  was  not  detect
C1able in  the serum, and  the liver biopsy was repeated.
Thereafter, treatment  with the extract was continued,
encouraged  by  slight  improvement  in  the  child's
condition  and in  her electrocardiographic  tracings.
RESULTS  AND  COMMENTS
In the  preinfusion specimen  of the liver, the glyco-
gen  concentration  was  increased  and  the  activity
of a  glucosidase  was  barely  measurable.  In  the
postinfusion  specimen,  the  concentration  of
hepatic glycogen  was normal and the a  glucosidase
activity  was  more  than  twice  the  highest  value
obtained  in  24  "normal"  biopsy  specimens  of
human liver  (Table  I).
TABLE  I
Biochemical  Analysis  of  Liver  Biopsy  Specimens
Tissue  Glycogen*  a glhcosidase
Normal  2.0 6.0  0.183-0.679§
Patient
Before  treatment  7.8  0.004
After  treatment  2.9  1.62
* Expressed  as per cent  of wet  tissue weight.
Expressed  as  moles  of glucose  liberated  from
glycogen/min/g  of tissue.
§ Range  of 24  biopsies.
FIGURE  1  Preinfusion  specimen.  Ahnormal  lysosomes  filled  with glycogen  are present in every  hepato-
cyte.  X  5,000.
C2  C  M  M  U  N  I  C  A  T  I O  N  SFIGURE  2  Preinfusion  specimen.  The  picture is  dominated  by the abnormal  lysosonles  filled  with  lyso-
somal glycogen.  The cytoplasmic  glycogen  appears not abnormal.  X 21,000.
FIGURE  3  Preinfusion  specimen.  There are two abnormal  lysosomes  of small  to moderate size.  The lyso-
somal glycogen  is surrounded  by a membrane.  X  60,000.FIGURE 4  Postinfusion  specimen.  The  glycogen-filled  lysosomes  of  the  preinfusion  specimen  have  dis-
appeared.  X  5,000.
Electron  photomicrographs  of  the  preinfusion
specimen  showed  the  characteristic  abnormal
lysosomes  packed  with  lysosomal  glycogen.
Notable was their abundance  in every hepatocyte.
In  addition,  there  was  cytoplasmic  glycogen
predominantly  of  the  multigranular  variety  (a
particles)  Otherwise  the  cytoplasmic  glycogen
was  similar  to  that  seen  in  normal  liver  (Figs.
1-3).  After  18  days  of  enzyme  administration,
the  cytoplasmic  glycogen  appeared  unchanged.
However,  the  glycogen-filled  lysosomes  had  dis-
appeared.  Instead  there  were  structures  smaller
than  the  abnormal  lysosomes  of  the  preinfusion
specimen  and  occurring  about  one-fifth  as  fre-
quently.  Usually  they  were  empty  or  contained
some  cellular  debris,  feathery  material,  and  fine
granules.  Some  contained  a  few  glycogen  par-
ticles,  mostly  of the multigranular  variety.  These
structures  had  a  tendency  to  be  located  in  the
vicinity  of cell  borders  and  bile  canaliculi  (Figs.
4-6).  On  light  microscopic  examination,  the
postinfusion  specimen  could  not  be  distinguished
from  normal  human  liver,  whereas  hepatic  tissue
of untreated  Type  II  glycogenosis  had  the  char-
acteristic  abnormalities  (8).
Admission  of  the  infused  enzymes  into  the
hepatocyte  might  be by pinocytosis,  which would
provide  vesicles  surrounded  by  membranes.  The
membranes  would  separate  the  enzymes  from the
cytoplasmic  glycogen  thus preventing  its degrada-
C4  CO  M  M  I  N  I  C  A  T  I  O  N FIGURE  5  Postinfusion  specimen.  There are  a  few nearly  empty  vacuoles  usually  located  close  to  cell
borders  or bile canaliculi  (BC).  Rarely,  they contain some  glycogen particles  (arrows).  X  15,000.
tion.  The  pinocytotic  vesicles  might  then  fuse
with  the  abnormal  lysosomes  allowing  the  Asper-
gillus  niger  enzymes  to  degrade  the  lysosomal
glycogen.  Presumably  lysosomes  would  continue
to  be  formed  during  the  enzyme  administration;
however,  the  partially  empty  structures  of  the
postinfusion  specimen  cannot  be  adequately
explained  with  the  available  information.
Acknowledgments  are  due  to  Dr. Kathryn  Edwards,
whose  patient  we  studied,  and  to  Mrs.  Gail  Chuck
and  Mrs.  Ruby  Cole  for  their  excellent  assistance.
This  investigation  was  supported  by  grant  No.
AM  08528  from  the Division of Arthritis  and  Meta-
bolic  Diseases  and  Grant  No.  FR  00123  from  the
General  Clinical  Research  Centers  Branch,  of the
National  Institutes of Health.
Received for publication 26 June 1967.
C  O  M  M  U  N  I  C  A  T  I O  N  S C5FIGURE  6  Postinfusion  specimen.  There  are  two  large-sized  vacuoles  which  are  surrounded  by  mem-
branes  and  do  not  contain  glycogen.  These  structures  are  usually  about  the  size  of  mitochondria  and
seem delineated occasionally by double membranes.  Their identity is uncertain.  The cytoplasmic  glycogen
is mostly of the a variety. X  60,000.
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